{
  "ptid_time": "130_S_5231_2013-07-16",
  "img_path": "/data/qiuhui/data/adni/images/130_S_5231/2013-07-16/t1.nii.gz",
  "img_finding": "Image findings: hippocampal volume measures 5,212 mm³, 26.7% below the reference mean. With a Z-score of -2.45 (0.7th percentile), this represents significant atrophy. ",
  "text_data": "Age is 74.2 years. Gender is Female. Education: 12 years. Handedness: Right. Race: White. Medical history: Cardiovascular; Allergies or Drug Sensitivities; Major Surgical Procedures. MMSE: 26.0. MoCA: 20.0. Logical Memory: 0.0. APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 1.59 SUVR (profound elevated); Amyloid beta: 647.10 pg/mL (normal ); Total tau: 320.70 pg/mL (mild elevated); Phosphorylated tau: 32.86 pg/mL (mild elevated). ",
  "true_diagnosis": "Diagnosis: AD.",
  "gpt_diagnosis": "**Reasoning:** The hippocampal volume is significantly reduced (Z-score -2.45, 0.7th percentile), indicating substantial atrophy. While MMSE is borderline normal (26), MoCA (20) suggests cognitive impairment, and biomarker findings (elevated AV45, mild tau elevation with normal Aβ) are atypical but may suggest tauopathy or non-AD pathology.  \n\n**Diagnosis:** **MCI** (given cognitive deficits but preserved independence; biomarker profile complicates AD diagnosis).  \n**Confidence:** **Medium** (due to conflicting biomarkers and lack of clear functional decline for dementia).",
  "timestamp": "2025-07-26T14:58:38.685862"
}